Condition: Age-related Macular Degeneration · Sponsor: Massachusetts Eye and Ear Infirmary
interventional trial for off label use of high dose atorvastatin 80 mg in intermediate AMD patients and correlate recovery response measured by dark adaptation recovery time with drusen volume reduction measured by SD-OCT
This description comes directly from the study's public registry record.
John B Miller, MD · 617-573-3750 · John_miller@meei.harvard.edu
Deeba Husain · 617-573-3750 · Deeba_Husain@meei.harvard.edu
Always discuss trial participation with your own doctor first.
| Massachusetts Eye and Ear Infirmary | Boston, Massachusetts, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04735263